CU Cancer Center opens phase I clinical trial of anti-cancer stem cell agent OMP-54F28
The University of Colorado Cancer Center, together with other participating academic medical centers, recently opened a phase I human clinical trial of the drug OMP-54F28 in patients with advanced solid tumor cancers. OMP-54F28, ...
Oct 3, 2012
0
0